Global Hemoglobin A1c Monitoring Industry
2. EUROPE III-20
A.Market Analysis III-20
Current & Future Analysis III-20
Sizeable Expansion Prospects Lie Ahead of European DiabetesDiagnostics Market III-20 Factors Restricting Growth of Diabetes Diagnostics market III-20 Competitive Environment III-21 Siemens Dominates the European HbA1c Market III-21 Table 17: Leading Players in the European Point-of-Care HbA1c Tests Market (2011E): Percentage Breakdown of Revenues for Siemens Healthcare Diagnostics, Axis-Shield, Homecue and Others (includes corresponding Graph/Chart) III-21 Significant Diversity Exists in POC Test Adoption III-21 Diabetes Statistics in Europe III-22 Table 18: European Diabetes and Population Statistics (2010 & 2030) III-22 Table 19: European Population and Diabetes Prevalence Statistics (2010 Estimates) - Top Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart) III-23 Key Diabetes Statistics in the UK III-24 Product Approvals/Launches III-24 Strategic Corporate Developments III-28 Select Key Players III-29 B.Market Analytics III-32 Table 20: European Recent Past, Current and Future Analysis for HbA1c Monitoring Market - Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart) III-32 Table 21: European Historic Review for HbA1c Monitoring Market - Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart) III-33 3. REST OF WORLD III-34 A.Market Analysis III-34 Current & Future Analysis III-34 POC Testing Rises in Japan, Physician's Office Testing Lags Behind III-34 Diabetes Statistics In Select Regions/Countries Under Rest of World III-34 Canada III-34 Latin America III-35 Table 22: Central and South American Diabetes and Population Statistics (2010 & 2030) III-35 Table 23: Central and South American Population (in Thousands) and Diabetes Prevalence Statistics (2010 Estimates) - Top Regions with High Prevalence of Diabetes by Gender (includes corresponding Graph/Chart) III-36 Asia-Pacific III-37 Table 24: Western Pacific Diabetes and Population Statistics (2010 & 2030) III-37
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV